Kiminobu Sugaya | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kiminobu Sugaya

Kiminobu Sugaya Burnett School of Biomedical Sciences
College of Medicine
University of Central Florida
Orlando, FL 32827, USA


Kiminobu Sugaya research focus is to develop stem cell therapies for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and ALS.He reported that human fetal neural stem cells transplanted into 24-month-old rats developed into neural cells and significantly improved the cognitive function of the animals.


Global Speakers in the subject

Global Experts in the subject